Search Results - "Urru SAM"

Behavioural theories, models and frameworks to underpin clinical pharmacy and pharmacy practice research: guidance from the European Society of Clinical Pharmacy.

Authors: Weidmann AE Cadogan C Fialová D et al.

Source: International journal of clinical pharmacy [Int J Clin Pharm] 2025 Oct; Vol. 47 (5), pp. 1537-1543. Date of Electronic Publication: 2025 Jul 21.

Publication Type: Journal Article

Journal Info: Publisher: Springer Country of Publication: Netherlands NLM ID: 101554912 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2210-7711 (Electronic) NLM ISO Abbreviation: Int J Clin Pharm Subsets: MEDLINE

Real-world evaluation of health-related quality of life in hematology patients treated with rituximab: results of a multicentric cross-sectional cohort study.

Authors: Urru SAM Mayer F Spila Alegiani S et al.

Corporate Authors: Urru SAM Mayer F Spila Alegiani S et al.

Source: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation [Qual Life Res] 2026 Mar 01; Vol. 35 (4). Date of Electronic Publication: 2026 Mar 01.

Publication Type: Journal Article; Multicenter Study; Observational Study

Journal Info: Publisher: Springer Netherlands Country of Publication: Netherlands NLM ID: 9210257 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-2649 (Electronic) Linking ISSN: 09629343 NLM ISO Abbreviation: Qual Life Res Subsets: MEDLINE

Frequency of Biological Drug Use in Older Patients with Immune-Mediated Inflammatory Diseases: Results from the Large-Scale Italian VALORE Distributed Database Network.

Authors: Soardo F Spini A Pellegrini G et al.

Source: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy [BioDrugs] 2025 May; Vol. 39 (3), pp. 499-512. Date of Electronic Publication: 2025 Apr 03.

Publication Type: Journal Article

Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9705305 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-190X (Electronic) Linking ISSN: 11738804 NLM ISO Abbreviation: BioDrugs Subsets: MEDLINE

Safety profiles of biosimilars vs. their EU reference products: INNs (adalimumab, bevacizumab, trastuzumab, rituximab, infliximab, etanercept).

Authors: Kopanarov, Valentin Benisheva, Tatyana Naydenova, Radoslava et al.

Source: Biotechnology & Biotechnological Equipment. Dec2025, Vol. 39 Issue 1, p1-15. 15p.

Formulation and clinical evaluation of carbidopa/levodopa oral solution for the treatment of sepiapterin reductase deficiency.

Authors: Maines E Temporin G Fedrizzi M et al.

Source: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V [Eur J Pharm Biopharm] 2024 Oct; Vol. 203, pp. 114429. Date of Electronic Publication: 2024 Aug 07.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 9109778 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-3441 (Electronic) Linking ISSN: 09396411 NLM ISO Abbreviation: Eur J Pharm Biopharm Subsets: MEDLINE

Early detection of triple-negative breast cancer: evidence of a favourable prognostic impact in a comparative analysis of screen-detected versus symptomatic cases.

Authors: Castellano, Isabella Rousset, Stefano Casella, Denise et al.

Source: BMC Cancer. 4/18/2025, Vol. 25 Issue 1, p1-11. 11p.

Occlusive Vasculitis Following Intravitreal Rituximab Injection for Primary Vitreoretinal Lymphoma.

Authors: Cole, Emily D. Dedania, Vaidehi Demirci, Hakan

Source: Ocular Immunology & Inflammation. Jan2025, Vol. 33 Issue 1, p161-165. 5p.

Cepharanthine inhibits lysosomes and induces apoptosis in triple-negative breast cancer cells.

Authors: Li, Juan Zhou, Siqin Wang, Yu et al.

Source: Molecular Medicine Reports. Jul2026, Vol. 34 Issue 1, pN.PAG-N.PAG. 1p.

Modified neoadjuvant clinicopathological risk stratification as a prognostic score in early and locally advanced triple-negative breast cancer.

Authors: Dubashi, Biswajit Matta, Kirankumar Kayal, Smita et al.

Source: Journal of Cancer Research & Therapeutics. Jan-Mar2022, Vol. 18 Issue 1, p168-172. 5p.

Drug-induced insulin autoimmune syndrome: a clinico-epidemiological analysis integrating pharmacovigilance data and case series.

Authors: Yu, Xiuheng Li, Min Liao, Yi et al.

Source: Diabetology & Metabolic Syndrome. 10/9/2025, Vol. 17 Issue 1, p1-14. 14p.

Burden of Disease and Cost of Illness of Triple-Negative Breast Cancer in Portugal.

Authors: Silva, Joana Sousa, Gabriela Costa, Luís et al.

Source: PharmacoEconomics - Open. May2025, Vol. 9 Issue 3, p423-431. 9p.

The comparison of safety and cost between reference drug of rituximab and its biosimilar Riximyo in lymphoproliferative disorders and other hematological diseases. Single center experience.

Authors: Olszewska-Szopa, Magdalena Ożańska, Agnieszka Ożański, Tomasz et al.

Source: Leukemia & Lymphoma. Jan2024, Vol. 65 Issue 1, p55-61. 7p.

The third-generation anti-CD30 CAR T-cells specifically homing to the tumor and mediating powerful antitumor activity.

Authors: Zhang, Shangkun Gu, Chaojiang Huang, Lifang et al.

Source: Scientific Reports. 6/21/2022, Vol. 12 Issue 1, p1-12. 12p.

Prognostic value of tumor necrosis based on the evaluation of frequency in invasive breast cancer.

Authors: Chen, Jianhua Li, Zhijun Han, Zhonghua et al.

Source: BMC Cancer. 6/9/2023n, Vol. 23 Issue 1, p1-14. 14p.

Repurposing the anti-parasitic agent pentamidine for cancer therapy; a novel approach with promising anti-tumor properties.

Authors: Rastegar-Pouyani, Nima Farzin, Mohammad Amin Zafari, Jaber et al.

Source: Journal of Translational Medicine. 3/3/2025, Vol. 23 Issue 1, p1-20. 20p.

Sex-Related Differences in Circular RNA Expression in Multiple Sclerosis: A Pilot Study.

Authors: Lodde V Zarbo IR Farina G et al.

Source: Journal of molecular neuroscience : MN [J Mol Neurosci] 2026 May 26; Vol. 76 (2). Date of Electronic Publication: 2026 May 26.

Publication Type: Journal Article

Journal Info: Publisher: Humana Press Country of Publication: United States NLM ID: 9002991 Publication Model: Electronic Cited Medium: Internet ISSN: 1559-1166 (Electronic) Linking ISSN: 08958696 NLM ISO Abbreviation: J Mol Neurosci Subsets: MEDLINE

Safety and tolerability of a 90‐minute rapid infusion of Sandoz biosimilar rituximab in B‐cell lymphoproliferative disorders in a real‐world setting.

Authors: Muntañola, Ana Arguiñano‐Pérez, José María Dávila, Julio et al.

Source: CTS: Clinical & Translational Science. Feb2023, Vol. 16 Issue 2, p305-312. 8p.

Histologic subtyping affecting outcome of triple negative breast cancer: a large Sardinian population-based analysis.

Authors: Sanges, Francesca Floris, Matteo Cossu-Rocca, Paolo et al.

Source: BMC Cancer. 6/2/2020, Vol. 20 Issue 1, p1-14. 14p. 4 Charts, 1 Graph.

A novel and atypical NF-KB pro-inflammatory program regulated by a CamKII-proteasome axis is involved in the early activation of Muller glia by high glucose.

Authors: Sbardella, Diego Tundo, Grazia Raffaella Mecchia, Alice et al.

Source: Cell & Bioscience. 7/16/2022, Vol. 12 Issue 1, p1-21. 21p.

Impact of kidney size on the outcome of diabetic patients receiving hemodialysis.

Authors: Wang, Min Hsu, Hsin-Chiao Yu, Mei-Ching et al.

Source: PLoS ONE. 3/31/2022, Vol. 17 Issue 3, p1-14. 14p.